Evaluation of post operative pain and stress after cataract surgery after gabapentin pretreatment: a single-blind clinical trial

Not Applicable

• Conditions: Cataract Surgery.

• Registration Number: IRCT20211216053424N1
• Lead Sponsor: Oroumia University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 May 2022

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

Age between 18 to 75 years
Class 1 and 2 patients based on American society of Anesthesiologist (ASA) Classification (Class 1 includes individuals without underlying disease and Class 2 includes individuals with mild underlying disease)
Cataract surgery
consent to participate in the study

Exclusion Criteria

Emergency surgeries
Allergic reaction to Gabapentin
BMI more than 35 kg/m2
Psychologic disorders
Autoimmune disorders
Diabetes mellitus
Warfarin use
Opium or alcohol addiction
History of Malignancy and tumor resection surgery

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The effect of gabapentin pretreatment on pain severity based on Visual analogue Scale. Timepoint: 15 minutes before surgery, when discharge from recovery, 12 hours and 24 hours after surgery. Method of measurement: Visual analogue Scale.

Secondary Outcome Measures

Name	Time	Method
Evaluation of the effect of gabapentin pretreatment on stress level based on GAD-7 after's cataract surgery. Timepoint: 15 minutes before surgery, at the time of discharge from recovery, 12 hours and 24 hours after surgery. Method of measurement: General Anxiety Disorder Assessment (GAD-7).